177 related articles for article (PubMed ID: 798473)
1. The alternative pathway of complement activation.
Götze O; Müller-Eberhard HJ
Adv Immunol; 1976; 24():1-35. PubMed ID: 798473
[No Abstract] [Full Text] [Related]
2. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
3. C3 and C5-cleaving properdin enzymes formed on zymosan incubated with human serum: the decay and the regeneration of the enzymes.
Fujita T; Takiuchi M; Matsumoto M; Nagaki K; Inai S
Int Arch Allergy Appl Immunol; 1977; 53(4):303-9. PubMed ID: 67089
[TBL] [Abstract][Full Text] [Related]
4. Babesia rodhaini: requirement of complement for penetration of human erythrocytes.
Chapman WE; Ward PA
Science; 1977 Apr; 196(4285):67-70. PubMed ID: 841340
[TBL] [Abstract][Full Text] [Related]
5. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
6. [Complement activation and biological activities].
Inoue K
Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
[No Abstract] [Full Text] [Related]
7. A molecular concept of the properdin pathway.
Medicus RG; Schreiber RD; Götze O; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1976 Feb; 73(2):612-6. PubMed ID: 54923
[TBL] [Abstract][Full Text] [Related]
8. Activation of the alternative (properdin) pathway by divalent cations.
Lew FT; Yukiyama Y; Waks HS; Osler AG
J Immunol; 1975 Sep; 115(3):884-8. PubMed ID: 807649
[TBL] [Abstract][Full Text] [Related]
9. The natural modulation of the amplification phase of complement activation.
Fearon DT; Daha MR; Weiler JM; Austen KF
Transplant Rev; 1976; 32():12-25. PubMed ID: 62426
[TBL] [Abstract][Full Text] [Related]
10. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
Schreiber RD; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
[TBL] [Abstract][Full Text] [Related]
11. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Glomerulonephritis, complement and C3NeF.
Fearon DT
N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
[No Abstract] [Full Text] [Related]
13. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
14. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
Fearon DT; Austen KF
J Exp Med; 1975 Oct; 142(4):856-63. PubMed ID: 1185108
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin and complement deposits in lupus glomerulonephritis.
Méry JP; Morel-Maroger L; Boelaert J
Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
[No Abstract] [Full Text] [Related]
16. Genetics of the complement system.
Alper CA; Rosen FS
Adv Hum Genet; 1976; 7():141-88. PubMed ID: 827931
[No Abstract] [Full Text] [Related]
17. Complement activation in acute glomerulonephritis in children.
Levy M; Sich M; Pirotzky E; Habib R
Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
[No Abstract] [Full Text] [Related]
18. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
Schreiber RD; Medicus RG; Gïtze O; Müller-Eberhard HJ
J Exp Med; 1975 Sep; 142(3):760-72. PubMed ID: 1165475
[TBL] [Abstract][Full Text] [Related]
19. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
[TBL] [Abstract][Full Text] [Related]
20. The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate.
Fujita T; Takiuchi M; Iida K; Nagaki K; Inai S
Immunochemistry; 1977 Jan; 14(1):25-30. PubMed ID: 849874
[No Abstract] [Full Text] [Related]
[Next] [New Search]